Therefore, these observations strongly supported that ATP6V0B identified by our ExCy isolation and statistical algorithm pipeline is specifically associated with EV biology within the context of pancreatic cancer, indicating a successful discovery of novel early-stage pancreatic tumor marker. This evidence concerns the gene ATP6V0B and familial pancreatic carcinoma.